Insider Holders & Insider Ownership - PROGENICS PHARMACEUTICALS INC (PGNX)

List of insiders holdings for PROGENICS PHARMACEUTICALS INC:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
Velan Capital L.P.
Altiva Management Inc.
VENKATARAMAN BALAJI
See Explanation of Responses
10% Owner
2020-04-15 15:15:288,011,733
0
8,011,733Form 13D
LTE Partners LLC
Melkonian Capital Management LLC
LTE Management LLC
Melkonian Ryan
See Explanation of Responses
10% Owner
2019-09-09 18:14:161,950,000
0
1,950,000Form 4
MADDON PAUL J
Director
2016-04-22 17:09:42909,891
0
909,891Form 4/A
Baker Mark Robert
Chief Executive Officer
2019-03-05 15:49:30192,500
0
192,500Form 4
JACOBSON PAUL F
Director
2008-10-24 16:34:22125,600
0
125,600Form 4
Nohria Virinder
See Explanation of Responses
10% Owner
2019-08-27 15:39:59110,000
0
110,000Form 3
Summer Jeffery
SVP, Digital Technology
2018-03-02 13:57:3794,875
0
94,875Form 4
Hirt Sheldon
Executive VP & General Counsel
2016-03-03 14:34:1382,500
0
82,500Form 4
Fabbio Patrick
CFO
2020-03-04 16:15:0282,214
0
82,214Form 4
Boyd Thomas A
Sr. VP, Product Dev.
2010-07-06 14:16:3379,436
0
79,436Form 4
Youssoufian Hagop
Executive Vice President R&D
2014-03-04 15:32:5166,000
0
66,000Form 4
Olson William C
Senior VP, Research and Develo
2013-04-08 15:58:0060,000
0
60,000Form 4
Crowley Peter J
Director
2019-07-15 09:01:3955,000
0
55,000Form 4
Lovallo Angelo William JR
Vice President Finance
2015-03-04 11:27:3352,800
0
52,800Form 4
MCKINNEY ROBERT A
Senior VP, CFO
2012-03-05 14:23:5850,000
0
50,000Form 4
YACHMETZ PHILIP K
VP, General Counsel
2004-05-05 17:18:2340,696
200
40,896Form 4
Cooke Terence
See Explanation of Responses
10% Owner
2019-08-27 15:25:1540,000
0
40,000Form 3
ISRAEL ROBERT J
Executive Vice President, Medi
2015-06-15 09:32:3739,050
0
39,050Form 4
PRENTKI RONALD J
President
2005-02-17 18:27:5835,672
0
35,672Form 4
Kremer Alton B
VP, Clinical Research
2008-04-03 17:09:5728,173
0
28,173Form 4
KISHBAUCH MICHAEL D
Director
2019-07-15 09:02:0325,000
0
25,000Form 4
WILLIAMS NICOLE
Director
2019-07-15 09:02:3325,000
0
25,000Form 4
SCHEINBERG DAVID A
Director
2019-07-15 09:02:2125,000
0
25,000Form 4
GOFF STEPHEN P
Director
2013-06-20 15:43:2720,000
0
20,000Form 4
BAKER CHARLES A
Director
2012-06-14 14:57:1510,000
0
10,000Form 4
BRINER KURT W
Director
2012-06-14 14:56:4510,000
0
10,000Form 4
DALTON MARK F
Director
2011-07-06 19:01:1710,000
0
10,000Form 4
Ferrante Karen Jean
Director
2020-06-23 16:47:070
0
0Form 4
Das Asha
Chief Medical Officer
2020-06-23 16:49:430
0
0Form 4
Osorio Benedict
COO
2020-06-23 16:49:250
0
0Form 4
Tenbarge Bryce
SVP, Commercial
2020-06-23 16:49:040
0
0Form 4
Wong Vivien
EVP, Development
2020-06-23 16:48:470
0
0Form 4
Mims David W.
Interim CEO and Interim CFO
2020-06-23 16:48:250
0
0Form 4
Ber Gerard
Director
2020-06-23 16:48:050
0
0Form 4
Campbell Bradley L
Director
2020-06-23 16:47:460
0
0Form 4
Ende Eric J
Director
2020-06-23 16:47:260
0
0Form 4
MacDougall Ann L.
Director
2020-06-23 16:46:470
0
0Form 4
Maeusli Heinz Christoph
Director
2020-06-23 16:46:240
0
0Form 4
Sarpangal Deepak
See Explanation of Responses
10% Owner
2019-08-27 15:29:070
0
0Form 3
Broadfin Healthcare Master Fund Ltd
Broadfin Capital LLC
KOTLER KEVIN
10% Owner
2018-02-13 16:57:520
0
0Form 13G